International Journal of Reproductive BioMedicine Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences of Yazd ISSN: 1680-6433 EISSN: 2008-2177 Vol. 9, Num. 3, 2011, pp. 187-192

Iranian Journal of Reproductive Medicine Vol.9. No.3. pp: 187-192

Icodextrin reduces adhesion formation following gynecological surgery in rabbits

Behnaz Khani¹M.D., Nahid Bahrami² M.D., Ferdous Mehrabian² M.D., Hormoz Naderi Naeni³ M.D.

¹Department of Obstetrics and Gynecology, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
²Department of Obstetrics and Gynecology, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
³Sepahan Hospital, Isfahan, Iran.

Corresponding Author:
*Behnaz Khani, Flezi Bridge, Shahid Beheshti Hospital, Isfahan, Iran.
*Email: khani@med.mui.ac.ir

Received: 8 May 2010; accepted: 11 January 2011

Code Number: rm11028

Background: Adhesion is a common complication of gynecology surgery so different barrier agents and solutions have been used during these operations to separate and protect tissues from adhesion after surgery. Adept is one of these solutions that have been postulated to reduce the chance of adhesion following gynecolgy surgery.

Objective: To evaluate the effect of 4% icodextrin in reducing adhesion formation in comparing with sterile water and human amniotic fluid in rabbits.

Materials and Methods: In this prospective experimental study 30 white Newzealand female rabbits were selected and randomized in to three treatment groups. The rabbits were anesthetized and an abdominal incison was made, uterine horns were abrated with gauze until bleeding occurred. Before closing the abdomen, the traumatized area was irrigated either by 30cc of sterile water, 30cc of 4% Adept or 30cc of human amniotic fluid. The solutions were labeled only as solutions A (steriel water), B (icodextrin), or C (human amniotic fluid). On the seventh day after surgery, second laparotomy was performed to determine and compare adhesion formation in rabbits.

Results: There was significant difference between mean score of adhesions in 4% icodextrin group (2.1±0.70) in comparison to sterile water group (10.4±0.60) and amniotic fluid group (8.7±0.84). But the difference between mean score of adhesions in amniotic fluid group in comparison to sterile water group was not significant (8.7±0.84) versus (10.4±0.60).

Conclusion: The use of 4% icodextrin solution was more effective than human amniotic fluid and sterile water in reducing adhesion formation in a gynecological surgery model in rabbits

Key words: Icodextrin solution, Human amniotic fluid, Adhesion formation, Rabbit.

Introduction

Adhesions are the most common cause of post operative small bowel obstruction, infertility and visceral pain (1). Pelvic surgery is associated with high rates of pelvic adhesion formation. Careful surgical techniques have been proved to reduce adhesion formation. Application of fine, Non-reactive suture materials and prevention of foreign-body reaction, excision of necrotic tissue and minimizing tissue and organ injury are effective in reducing adhesion formation in a surgical procedure (2).

Non surgical techniques such as application of local and systemic anti-inflammatory agents and peritoneal instillates have been used in this regard. Anti adhesion barriers such as hyaluronic acid, polyethylene glycol, fibrin glue, hyaluronic acid film, and expanded polytetrafluoroethylene have been shown to reduce the incidence and extent of new and recurrent adhesions in different clinical trials (3, 4).

The use of fluids in the peritoneal cavity to separate surfaces and prevent adhesion formation between organs is under investigation. One of these fluids is human amniotic fluid which is a hypotonic solution mainly contains albumin, cholesterol and hyaluoronic acid, existance of hyaluoronic acid in the peritoneal cavity shifts the repair process into regeneration pathway and decreases fibrosis and scar formation. Amniotic fluid also contains some potent growth factors such as insulin like growth factors that are involved in repair process (5).

In our study, human amniotic fluid was selected and compared with adept adhesion reduction solution that is a pale yellow fluid (icodextrin w/v 4% solution) and is a non viscous, iso-osmotic, clear solution, contains icodextrin, alpha-1, 4 linked glucose polymer with a molecular weight of 16,500 Daltons.

This product is not physiologically present in the abdominal cavity; it remains in the peritoneal cavity for 3- 5 days before absorption by the lymphatic system and therefore resides longer compared to other solutions such as saline and a glucose-based peritoneal dialysis solution. The existence of 4% icodextrin in the peritoneal cavity during this critical period separates damaged surfaces and minimizes adhesion formation between organs. It gradually absorbs into the blood stream and is broken down by amylase and metabolized to glucose (6).

In a controlled pilot study, the safety and efficacy of 4% icodextrin was evaluated after laparoscopic gynecological surgery and the results showed that it is effective in reducing adhesion formation (7).

Also in another randomized blinded trial anti adhesion efficacy of 4% icodextrin, ferric hyaluronate gel and Ringer lactat were compared in sever peritoneal damage caused by bipolar coagulation in a laparoscopic rat model. Adhesins were more filmier and easily separable in 4% icodextrin group comparing with Ringer lactate group (8).

In contrast to these research results some other working groups found insufficient effects of 4% icodextrin in animal models (9, 10). Two cases of severe serosal fibrosis within a few days after usig 4% icodextrin for reducing adhesion in abdominal surgery was reported (11). Numerous cases of abdominal pain and sterile chemical peritonitis have been contributed to 4% icodextrin (12).

Because the bio compatibility and efficacy of 4% icodextrin is the subject of controversial discussion in the current literature, we planned our study and used a rabbit model to evaluate the effectiveness of 4% icodextrin in reducing adhesion formation in comparing with sterile water and human amniotic fluid.

Materials and methods

This prospective experimental study was done in Physiology Department of Isfahan University of Medical Sciences, Isfahan, Iran and approved by institutional review board and vice chancellery research of this university by registry number of 386161.

30 white, Newzealand female rabbits, weighing 2000-2200g were randomly assigned to 3 groups. Each group consisted ten non pregnant, 12 weeks aged rabbits. They were fed with standard laboratory rabbit food and water throughout the study. Human amniotic fluid was taken in a sterile condition during cesarean section of two pregnant women who both were around 32 weeks pregnant and had the same indication of cesarean section. To remove red blood cells from the fluid it was centrifuged for ten minutes (3000circules/min) and kept in refrigerator for four hours before use. The 4% icodexterin solution was hydrochloride (Baxter healthcare corporation, Deerfield IL, USA) and the sterile water was from Daroupakhsh Company, Tehran, Iran. The gauze was from Safa Company, Isfahan, Iran.

The rabbits were anesthetized for surgery with IM injection of 55 mg/kg of ketamine. The abdominal ventral side was shaved and dis-infected with povidone iodine. A vertical 5cm abdominal incision was made. Uterine horns were exteriorized and the serosal surfaces of the horns were abraded with sterile gauze until bleeding occured. Up to this point, all animals received the same procedure but after that the injured area were irrigated with different solutions. The solutions were labelled only as A, B or C, so that the study personnel were blinded to solution identity.

The first group acted as control group in which 30cc of A solution was poured over the traumatized area. In the second group, the damaged area was irrigated with 30cc of B solution and the third group received 30cc of C solution before closure of the abdomen.

Measurements

The second laparotomy was carried out in 30 rabbits after 7 days to assess adhesion formation. The evaluations were blinded for three groups. The formed adhesions were scored by qualitative and quantitative parameters (Table I). Parameters included extent, depth of adhesion, bursting strength, and number of adhesion sites (13). The score from four parameters were calculated and added to define total adhesion score as the grade of adhesion (Table II) (13).

Statistical analysis

Adhesion scores were assessed by a blinded surgeon and the mean scores of adhesion were analyzed by SPSS software version 13 using Mann-Whitney test p<0.05 was considered statistically significant.

Results

In second laparotomy, 7 days later in the sterile water group, the occurrence of severe adhesions was evident. All rabbits in this group showed adhesions, 7 cases (70%) had severe adhesion (grade 3) and 3 cases (30%) had moderate adhesion (grade 2). In 4% icodextrin group, adhesions were found to develop only in 5 rabbits (50%) and half of cases displayed no adhesions at all. Adhesion in these 5 rabbits was merely low grade (grade 1). Finally, in the human amniotic fluid group all rabbits developed some extent of adhesion, 4 rabbits (40%) displayed severe adhesion, and another 4 cases (40%) showed moderate adhesion and the rest, 2 cases (20%) developed mild adhesion. The score of adhesion was calculated for each rabbit as mentioned above. Then the mean score for each group was measured and compared as shown in table III. The mean score of adhesion was (2.1±0.70) for 4% icodextrin group while the mean score was (10.4±0.60) for sterile water group, so the difference was statistically significant (p=0.000) (Table III).

In human amniotic fluid group the mean score was (8.7±0.84) and in comparison with sterile water group (10.4±0.60), the difference was not significant (p=0.10) (Table III).

Finally, there was a significant difference between the mean score of adhesion in 4% icodextrin group in comparison to amniotic fluid group.

Discussion

Because adhesion adveresely affects patient morbidity and is a great burden to health system, different techniques have been proposed and tested to reduce adhesion formation (14). Fine surgical techniques and use of laparoscopic surgery to minimize tissue damage are to some extent effective in this regard but Surgical and Clinical Adhesions Research study data showed that this is not sufficient to prevent adhesion formation (15). Administration of specific fluids such as lactated Ringer’s Solution (LRS), phosphate-buffered saline (PBS) and normal saline in to the peritoneal cavity during the surgery has been proposed to reduce formation of adhesions. However these solutions are absorbed in a short period of time and therefore are not effective clinically in preventing adhesion formation (16).

It was shown that administration of human amniotic fluid in to the peritoneal cavity inhibits production of expanded peritonitis. Human amniotic fluid contains hyaluoronic acid that promotes normal healing process (17) and also contains hyaluoronic acid stimulating activator (HASA) which stimulates scar cells to produce hyaluoronic acid that inhibits migration of lymphocytes and prevents chemotaxis and phagocytosis of granulocytes and therefore inhibits scar formation (18).

Four studies commented the prevalence of adhesions at second look laparoscopy (19-22) and showed evidence of decreased prevalence of adhesions in patients who were treated with hyaluronic acid compared with those given placebo or no treatment.

Our results also indicate that human amniotic fluid is more effective in reducing adhesion formation in comparison with sterill water as placebo. We used 4% icodextrin fluid because it has a longer residual time in the abdominal cavity in comparison to other solutions (23) and it was compared with human amniotic fluid which contains Hyaluronic acid that has been proposed to reduce adhesion formation too. Rabbits were our experimental model because the fluid dynamics of icodextrin in this species is more closely similar to human beings (24).

Early pre-clinical studies were performed (by Verco et al 2000) to assess the efficacy of 4% icodextrin in order to reduce adhesion in a rabbit double uterine horn model (25). Their results indicate that postoperative application of icodextrin 4% causes a significant increase in adhesion free sites (p=0.000).

In a randomized controlled study (by Dizerega et al 2003) the safety and efficacy of 4% icodextrin was evaluated. In order to compare icodextrin 4% with Ringer’s lactated saline, 62 women who required laparascopic adnexal surgery were compared in two different treatment groups. Results showed that lavage and instillation with icodextrin 4% was effective in reducing adhesion formation. The use of 4% icodextrin solution for peri operative lavage and post operative instillation in rabbit model of bowel anastomatic healing, didn’t result in any difference from either LRS treated or untreated surgical control (26).

In another study (by Muller et al 2005) the effect of intraperitoneal anti adhesive fluids (4% icodextrin, phospholipids, Ringer’s lactate) in a rat peritonitis model was examined and the results of 4% icodextrin showed significantly enhancement of adhesion and abscess formation, in comparison with the other control groups. A case of disseminated intra vascular coagulation after laparoscopic multiple myomectomy with the use of 4% icodextrin solution was described by Santos et al (2006). The possible cause might be idiosyncratic immunologically mediated reaction to icodextrin in the pelvic cavity, but no previous case of DIC has been described in the published litreture (27). Some cases of vulval edema, plural effusion and even anaphylactoeid reaction related to icodextrin 4% after laparoscopic and laparotomy surgery have been reported (28).

But, ARILE (Adept registry for clinical evaluation) was initiated in a number of centers in the UK and then expanded to involve 253 centeres (103 general-surgery and 150 gynecologyical-surgery centers) in France, Germany, Italy, Spain, Greece (gynecology only) and the UK. The findings indicate that icodextrin 4% was well tolerated by patients who underwent laparotomy or laparoscopy (29).

In a recent study (by Colins et al 2007), 402 patients randomized intraoperatively to receive either 4% icodextrin or LRS and then patients returned for second laparoscopy within 4–8 weeks. Incidence, severity, and extent of adhesions were characterized for both groups and they demonstrated that 4% icodextrin is a safe and effective adhesion reduction agent in laparoscopy (30).

Our study results support preclinical observation (by Verco et al 2000) and recent study (by Colin et al 2007), as mentioned before in adept group, half of the cases were found with no adhesion at all and the rest had mild adhesion.

However in our study, no side effects, no abscess formation and no other complication were observed in contrast to Muller et al (2005). Our data showed that lavage and instillation of 4% icodextrin was not only safe but also effective in reducing adhesion formation in rabbits, and with regard to close relationship of fluid dynamics in rabbits with human being this results suggest that patients undergoing gynelocological surgery may have a better prognosis for adhesion reduction after using intra operative irrigation with 4% icodextrin.

Acknowledgment

This research was supported by Vice Chancellery Research of Isfahan University of Medical Sciences and there is no conflict of interest in this article. The authors would like to thank IUMS and Dr. Mehdi Nematbakhsh, professor of Physiology Department of IUMS, and Miss Mojdeh Ghasemi, midwife, and Miss Zahra Samavatian for all their helps.

References

1. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001; 18: 260-273.
2. Muller SA, Treutner KH , Haase G , Kinzel S , Tietze L , Schumpelick V . Effect of intera peritonealanti adhesive fluids in a rat peritonitis model. Archsurg 2003; 138: 286-290.
3. Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents forpreventing adhesions after surgery for subfertility. Cochrane Database Syst Rev 2000; 2: CD000475.
4. Sekiba K. Use of Interceed (TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. The Obstetrics and Gynecology Adhesion Prevention Committee. Obstet Gynecol 1992; 79: 518-522.
5. Burd DA, Greco RM, Regauer S, Longaker MT, Siebert JW, Garg HG. Hyaluronan and wound healing: a newperspective. Br J PlastSurg 1991; 44: 579-584.
6. Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM. Fluid dynamics in man of an intra peritoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8: 9-12.
7. Dizerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D, et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17:1031-1038.
8. Roman H , Canis M , Kamble M , Botchorishvili R , Pouly JL , Mage G . Efficacy of three adhesion preventive agent in reducing severe peritoneal truma induced in a laparoscopic rat model. Fertil Steril 2005; 83: 1113-1118.
9. Muller SA, Treutner KH, Jorn H, Anurov M, Ottinger AP, Schumpelick V. Adhesion prevention comparing liquid and solid barriers in the rabbit uterine horn model. Eur J Obstet Gynecol Reprod Biol 2005; 120: 222-226.
10. Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2006; 19: CD001298.
11. Saedon M, Borowski DW , Natu S , Hennessy C , Tabaqchali MA . David W Borowski, SonaliNatu, Colm Hennessy. Adept (Icodextrin 4%): A tale of caution. Colorectal Dis 2010; 12: 384-386.
12. Reichel W, Schulze B, Dietze J, Mende W. A case of sterile peritonitis associated with icodextrin solution. Perit Dial Int 2001; 21: 414-419.
13. Kamffer WJ , Jooste EV , Nel JT , de Wet JI . Surgical glove powder and intraperitoneal adhesion formation. An appeal for the use of powder-free surgical gloves. S Afr Med J 1992; 81: 158-159.
14. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Dis 2002; 4: 355-360.
15. Lower AM, Hawthorn RJS, Ellis H, O’Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: anassessment from the SurgicalandClinical Adhesions Research Study. Br J Obstet Gynaecol 2000; 107: 855-862.
16. Lower AM, Hawthorn RJS, Clark D, Boyd JH, Finlayson AR, Knight AD, et al. Adhesionrelated readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24,046 patients. Hum Reprod 2004; 19: 1877-1885.
17. Rimbach S, Korell M, Tinneberg HR, DeWilde RL. Adhesions and their prevention in gynaecologic surgery: current status and consensus based on four workshops. Geburtsh Frauenheilk 2004; 64: 891-899.
18. Lancey JT. The prevention of peritoneal adhesions by amniotic fluid. Ann Surg 1930; 92: 281-293.
19. Longaker MT, Chiu ES, Harrison MR, Crombleholme TM, Langer JC, et al. Studies in fetal wound healing. IV. Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid. Ann Surg 1989; 667-672.
20. Johns DB , Keyport GM , Hoehler F , diZerega GS ; Intergel Adhesion Prevention Study Group . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertil Steril 2001; 76: 595-604.
21. Lundorff P, Geldorp H, Tronstad SE, Lalos O, Larsson B, Johns DB, et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Hum Reprod 2001; 16: 1982-1988.
22. Pellicano M, Bramante S, Cirillo D, Palomba S, Bifulco G, Zullo F, et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril 2003; 80: 441-444.
23. Rodgers KE, Verco SJS, diZerega GS. Effects of intraperitoneal 4% icodextrin solution onthe healing of bowel anastomoses and laparotomy incisions in rabbits. Colorectal Dis 2003; 5: 324-330.
24. Flessner MF, Lofthouse J. Of mice and men: species and age difference in dialysis withicodextrin. J Am Soc Nephrol 1999; 10: 226A.
25. Verco SJS, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G. Development of a novel glucose polymer solution (icodextrin) for adhesionprevention: pre-clinicalstudies. Hum Reprod 2000; 15: 1764-1772.
26. Rodgers KE, Verco SJ , diZerega GS . Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbit. Colorectal Dis 2003; 5: 324-330.
27. Santos LM, Frenna V , Thoma V , Wattiez A . Disseminated intravascular coagulation after laparoscopic multiple myomectomy with use of icodextrin. J Minim Invasive Gynecol 2006: 13, 480-482.
28. Doumplis D, Majeed GS, Sieunarine k, Richardson R, Smith JR. Adverse effects related to icodextrin 4% our experience.Gynecol Surg 2007; 4: 97-100.
29. Catena F, Ansaloni L, Lauro A, Ercolani G, D'Alessandro L, Pinna A. Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences. Trials 2008; 9: 74.
30. Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS, et al. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007; 88: 1413-1426.

The following images related to this document are available:

Photo images